Home Site Map Search Contact Us
portion of dmid header portion of dmid header
portion of dmid header portion of dmid header NIAID logo
portion of dmid header NIAID logo
left navigation arrow Research Programs, Press Releases, Meeting Information, Other Supported Programs, Publications & Other Resources Research Programs Press Releases Meeting Information Other Supported Programs Publications & Other Resources NIAID logo

Antimicrobial Resistance
Bacterial Infections
Biodefense
Childhood Infections
Drug Development
Emerging Infectious Diseases
Enteric Infections
Fungal Infections
Global Health
Hepatitis
Influenza
Lyme Disease
Malaria
Parasitic Infections Pathogen Genomics
Sexually Transmitted Diseases
Tuberculosis
Vaccines
Viral Infections


Global Health Research


Introduction
General Information

Research Plans & Priorities
Meetings


Introduction

The NIAID research program is predicated on the view that we live in a global community; we cannot separate the health problems of the United States from those of the rest of the world. In addition to the staggering human costs of disease, low health status has a profound impact on social and economic development, and frequently contributes to political instability.

As the NIAID faces the new millennium, we anticipate that our research efforts will result in new and improved vaccines, diagnostics, and treatments that will make "the highest attainable standard of health" a reality for a greater proportion of the global community. International collaborations such as the International Center for Tropical Disease Research, and The Gambia Pneumococcal Vaccine Trial have become a major focus of the NIAID global health research program. See also, Division of AIDS.

Key challenges facing global health efforts in the new millennium include the following:

  • The threat of emerging and re-emerging diseases (recent examples include the HIV/AIDS pandemic, West Nile virus in the United States, "mad cow" disease and new variant Creutzfeldt-Jakob disease in Europe, and the ever-present threat of pandemic influenza)
  • The spread of drug resistance seen in all classes of microbial pathogens
  • The threat of bioterrorism
  • The development of collaborative infrastructures and technologies to aid research and training at an international level

General Information

  1. Overviews




  2. Top of Page

  3. Fact Sheets


  4. Top of Page

  5. News Releases


  6. DMID Press Releases

    NIAID Newsroom

    Top of Page

  7. Reports and Articles from NIAID


  8. Top of Page

  9. Conference Proceedings


  10. Top of Page

  11. Staff Presentations and Papers


Research Plans & Priorities

  1. Opportunities & Resources


  2. Top of Page

  3. Ongoing Research


  4. Top of Page

  5. Clinical Trials


    1. EXTRAMURAL (International)

    2. INTRAMURAL

    Federally and Privately Supported Clinical Trials: clinicaltrials.gov

  6. Intramural Labs at NIAID


  7. (Note: All of the NIAID Intramural laboratories conduct research ultimately relevant to global health. The following represent only a small selection):

Meetings

Top of Page